Skip to content
Screener

Pediatrix Medical Group MD Operating Cash Flow

Operating Cash Flow at other companies

ARD
Ardent Health PartnersARDT
-$60.22M-143%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$970K-45.5%
Utah Medical Products logo
Utah Medical ProductsUTMD
$3.11M-30.4%
Nutex Health Inc. logo
Nutex Health Inc.NUTX
$34.2M+25.5%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$168M+78.7%
Tenet Healthcare logo
Tenet HealthcareTHC
$585M-37.5%

Other financials

Income statement

See full
Revenue$476.2M+3.9%
Operating income$41.7M+29.8%
Net income$29.6M+42.6%
EPS (diluted)$0.36+50.0%

Balance sheet

See full
Cash & equivalents$205.8M+108%
Total debt$629.7M-3.9%
Total equity$878.6M+11.3%
Total assets$2.1B+3.9%

Cash flow

See full
CapEx$6.2M+88.3%
Free cash flow-$136.1M-12.7%

Valuation

See full
Market cap$2.15B+71.3%
Enterprise value$2.58B+53.2%
P/E12.4×
P/S1.1×+0.5×

Profitability

See full
Operating margin11.3%
Net margin9%
FCF margin12.3%+2.5pp

Returns & leverage

See full
Return on equity20.9%
Debt / equity0.7×-0.1×
Current ratio1.3×-0.5×

Where this comes from

Reported directly by Pediatrix Medical Group in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The source filing: Pediatrix Medical Group’s 10-Q, filed May 5, 2026.

Filed
May 5, 2026, 7:00 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-204993
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Other liabilities(5,563)(6,149)
Net cash used in operating activities – continuing operations(129,502)(116,111)
Net cash used in operating activities - discontinued operations(345)(1,352)
Net cash used in operating activities(129,847)(117,463)
Cash flows from investing activities:
Acquisition payments, net of cash acquired(7,000)
Purchases of investments(7,008)(7,761)
Proceeds from maturities or sales of investments7,7507,300

Cover / Front Matter

FAQ

What is Pediatrix Medical Group's operating cash flow?
Pediatrix Medical Group (MD) reported operating cash flow of -$129.85M in Q1 2026.
How has Pediatrix Medical Group's operating cash flow changed year-over-year?
Pediatrix Medical Group's operating cash flow decreased by 10.5% year-over-year, from -$117.46M to -$129.85M.
What is the long-term trend for Pediatrix Medical Group's operating cash flow?
Over 4 years (2021 to 2025), Pediatrix Medical Group's operating cash flow has grown at a 37.1% compound annual growth rate (CAGR), from $76.74M to $271.09M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Ask your AI about Pediatrix Medical Group's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude